Home
>
R & D
>
Clinical Trials

Research and Development

Clinical Trials

Ongoing Clinical Trial Project Summary

Anticoagulation
A Multi-dose, tolerance and Pharmacokinetic-Pharmacodynamic study of Tecarfarin in Healthy Chinese Volunteers
Company
Zhaoke Pharmaceutical Guangzhou Limited
Therapeutic Area
Cardiovascular
Product
Tecarfarin
Phase
I
Official Project Name
A Multi-dose, tolerance and Pharmacokinetic-Pharmacodynamic study of Tecarfarin in Healthy Chinese Volunteers
ClinicalTrials.gov Identifier
CTR20192169
#of Sites
1
#of Patients
40
Status
Recruiting
Link
Primary Open Angle Glaucoma / Ocular Hypertension
A Multi-centers, Randomization, Single-blind, Positive-controlled, Parallel Clinical Trial to Evaluate the Efficacy and Safety of  Levobetaxolol Hydrochloride Eye Drops in Patients With Primary Open-angle Glaucoma
Company
China Ophthalmology Focus Limited
Therapeutic Area
Ophthalmology
Product
Levobetaxolol Hydrochloride Eye Drops
Phase
III
Official Project Name
A Multi-centers, Randomization, Single-blind, Positive-controlled, Parallel Clinical Trial to Evaluate the Efficacy and Safety of  Levobetaxolol Hydrochloride Eye Drops in Patients With Primary Open-angle Glaucoma
ClinicalTrials.gov Identifier
NCT02617459
#of Sites
23
#of Patients
366
Status
Recruiting
Link
Schizophrenia & Bipolar Disorder
A Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Staccato Loxapine (ADASUVE®) for Inhalation in Acutely Agitated Patients With Schizophrenia or Bipolar Disorder
Company
Zhaoke Pharmaceutical Guangzhou Limited
Therapeutic Area
Psychiatry
Product
Adasuve
Phase
III
Official Project Name
A Multi-center, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Staccato Loxapine (ADASUVE®) for Inhalation in Acutely Agitated Patients With Schizophrenia or Bipolar Disorder
ClinicalTrials.gov Identifier
NCT04148963
#of Sites
19
#of Patients
150
Status
Recruiting
Link
Anticoagulation
A Multi-dose, tolerance and Pharmacokinetic-Pharmacodynamic study of Tecarfarin in Healthy Chinese Volunteers
Company
Zhaoke Pharmaceutical Guangzhou Limited
Therapeutic Area
Cardiovascular
Product
Tecarfarin
Phase
I
Official Project Name
A Multi-dose, tolerance and Pharmacokinetic-Pharmacodynamic study of Tecarfarin in Healthy Chinese Volunteers
ClinicalTrials.gov Identifier
CTR20192169
#of Sites
1
#of Patients
40
Status
Recruiting
Link
Ovarian Epithelial Cancer / Fallopian Tube Cancer / Primary Peritoneal Cancer
A Phase I Clinical Study of Gimatecan (ST 1481) in Patients With Platinum-resistant or Sensitive Relapsing/Refractory Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Company
China Oncology Focus Limited
Therapeutic Area
Oncology
Product
Gimatecan
Phase
I
Official Project Name
A Phase I Clinical Study of Gimatecan (ST 1481) in Patients With Platinum-resistant or Sensitive Relapsing/Refractory Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier
CTR20192169
#of Sites
2
#of Patients
6-12
Status
Recruiting
Link
High-grade Gliomas
Single-center, Dose Escalation, Open Phase I Clinical Study of Oral TG02 Capsule in the Treatment of Recurrent / Progressive High-grade Glioma Patients With Failed TMZ Treatment
Company
China Oncology Focus Limited
Therapeutic Area
Oncology
Product
TG02
Phase
I
Official Project Name
Single-center, Dose Escalation, Open Phase I Clinical Study of Oral TG02 Capsule in the Treatment of Recurrent / Progressive High-grade Glioma Patients With Failed TMZ Treatment
ClinicalTrials.gov Identifier
NCT03904628
#of Sites
1
#of Patients
15
Status
Recruiting
Link
Cervical Cancer
An Open-label, Dose-escalation, Bi-weekly Phase I Clinical Trial in Treating Patients With Recurrent or Metastatic Cervical Cancer
Company
China Oncology Focus Limited
Therapeutic Area
Oncology
Product
ZKAB001
Phase
I+II
Official Project Name
An Open-label, Dose-escalation, Bi-weekly Phase I Clinical Trial in Treating Patients With Recurrent or Metastatic Cervical Cancer
ClinicalTrials.gov Identifier
NCT03676959
#of Sites
13
#of Patients
69
Status
Recruiting
Link
Extensive Stage Small Cell Lung Cancer
An Open-label, Dose-escalation, Bi-weekly Phase I Clinical Trial in Treating Patients With Recurrent or Metastatic Cervical Cancer
Company
China Oncology Focus Limited
Therapeutic Area
Oncology
Product
ZKAB001
Phase
Ib
Official Project Name
Phase Ib Study of Recombinant Anti-PD-L1 Monoclonal Antibody Injection (ZKAB001) Combined With Carboplatin and Etoposide in the Treatment of Extensive Small Cell Lung Cancer
ClinicalTrials.gov Identifier
NCT04346914
#of Sites
3
#of Patients
20
Status
Recruiting
Link
Urothelial Carcinoma
An Open-label, Dose-escalation, Bi-weekly Phase I+II Clinical Trial in Treating Patients With Locally Advanced and Metastatic Urothelial Carcinoma
Company
China Oncology Focus Limited
Therapeutic Area
Oncology
Product
ZKAB001
Phase
I+II
Official Project Name
An Open-label, Dose-escalation, Bi-weekly Phase I+II Clinical Trial in Treating Patients With Locally Advanced and Metastatic Urothelial Carcinoma
ClinicalTrials.gov Identifier
NCT03676946
#of Sites
1
#of Patients
10
Status
Phase2 -Recruiting
Link
Lee's Pharmaceutical (HK) Limited
1/F, Building 20E, Phase 3,
Hong Kong Science Park,
Shatin, Hong Kong
info@leespharm.com
+852 2314 1282
Contact Information
Drug Safety
9:00am to 6:00pm
drugsafety@leespharm.com
Investor Relations
LBS Communications Consulting Limited
Useful Links
Zhaoke Ophthalmology Ltd.
Lee’s Medical Explore
Follow Us
Lee's Pharm. Group
Zhaoke Pharmaceutical (Hefei) Company Limited
Lee’s Medical Explore
© Lee's Pharmaceutical Holdings Limited.
Terms of Use
Privacy Statement
Sitemap
Web Design by YSD